Ownership

William P. Forbes - Insider Trading & Ownership

Entity: Individual
Location: C/O Salix Pharmaceuticals, Ltd., 8510 Colonnade Center Drive, Raleigh, NC
Summary: The estimated net worth of William P. Forbes is at least $776K dollars as of February 4, 2025. William P. Forbes is the EVP, Chief Development Officer of HERON THERAPEUTICS, INC. /DE/ and owns shares of HERON THERAPEUTICS, INC. /DE/ (HRTX) stock worth about $776K.
All Insider Reports: All Insider Reports

Ownership of William P. Forbes

Symbol	Company	Relationship	Holdings Value	Report Period
HRTX	HERON THERAPEUTICS, INC. /DE/	EVP, Chief Development Officer	$776K	Jan 31, 2025
XAIR	Beyond Air, Inc.	Director		Nov 22, 2024
TRVI	Trevi Therapeutics, Inc.	Chief Development Officer		Jun 29, 2022

Showing 1 to 3 of 3 entries

Insider Transactions Reported by William P. Forbes:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
HRTX	Heron Therapeutics, Inc. /De/	Restricted Stock Units	Award		$0	0.00	+187K	187K	1/31/2025	Direct
HRTX	Heron Therapeutics, Inc. /De/	Employee Stock Option (Right to Buy)	Award		$0	0.00	+374K	374K	1/31/2025	Direct
HRTX	Heron Therapeutics, Inc. /De/	Common Stock	Options Exercise	+3.76%	$0		+3.87K	107K	1/19/2025	Direct
HRTX	Heron Therapeutics, Inc. /De/	Restricted Stock Units	Options Exercise	-7.69%	$0	0.00	-3.87K	46.5K	1/19/2025	Direct
XAIR	Beyond Air, Inc.	Stock Options (Right to buy)	Award		$0		+198K	45K	11/22/2024	Direct
XAIR	Beyond Air, Inc.	Stock Options (Right to buy)	Disposed to Issuer	-100%	$0		-198K	0	11/22/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Common Stock	Options Exercise	+3.9%	$0		+3.87K	103K	10/19/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Restricted Stock Units	Options Exercise	-7.14%	$0	0.00	-3.87K	50.4K	10/19/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Common Stock	Options Exercise	+4.06%	$0		+3.88K	99.2K	7/19/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Restricted Stock Units	Options Exercise	-6.67%	$0	0.00	-3.88K	54.2K	7/19/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Common Stock	Options Exercise	+15.1%	$0		+12.5K	95.4K	6/6/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Restricted Stock Units	Options Exercise	-25%	$0	0.00	-12.5K	37.5K	6/6/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Common Stock	Options Exercise	+4.9%	$0		+3.87K	82.9K	4/19/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Restricted Stock Units	Options Exercise	-6.25%	$0	0.00	-3.87K	58.1K	4/19/2024	Direct
XAIR	Beyond Air, Inc.	Stock Option (right to buy)	Award		$0	0.00	+45K	45K	3/20/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Employee Stock Option (Right to Buy)	Award		$0	0.00	+372K	372K	1/19/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Restricted Stock Units	Award		$0	0.00	+62K	62K	1/19/2024	Direct
HRTX	Heron Therapeutics, Inc. /De/	Common Stock	Purchase	+46.3%	$27.3K	1.09	+25K	79K	11/17/2023	Direct
HRTX	Heron Therapeutics, Inc. /De/	Common Stock	Purchase	+1250%	$47K	0.94	+50K	54K	11/16/2023	Direct
XAIR	Beyond Air, Inc.	Common Stock	Purchase	+50.7%	$33.4K	6.67	+5K	14.9K	3/31/2023	Direct
XAIR	Beyond Air, Inc.	Stock Option (right to buy)	Award		$0	0.00	+40K	40K	3/29/2023	Direct
XAIR	Beyond Air, Inc.	Common Stock	Purchase	+103%	$32.3K	6.46	+5K	9.86K	3/17/2023	Direct
TRVI	Trevi Therapeutics, Inc.	Performance Stock Options (right to buy)	Award		$0	0.00	+48K	48K	6/29/2022	Direct
XAIR	Beyond Air, Inc.	Stock Option (right to buy)	Award		$0	0.00	+30K	30K	3/3/2022	Direct
TRVI	Trevi Therapeutics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+138K	138K	2/11/2022	Direct

Previous1Next

Showing 1 to 25 of 25 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.